Hepatitis C generic drug, Velpanat, launched in Nepal
by Press Release from Outbreak News Today on (#27DTH)
Hyderabad, India based Natco Pharma Limited announced today that it has launched the first generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination in Nepal. Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination is sold by Gilead Sciences, Inc., under brand name Epclusa(R). Epclusa(R) is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype ["]
The post Hepatitis C generic drug, Velpanat, launched in Nepal appeared first on Outbreak News Today.